Author

Y. Yuki

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:flow cytometry· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

B. Lee· 2 shared D. Geanon· 2 shared G. Kelly· 2 shared M. Carrington· 2 shared M. Martin· 2 shared R. M. de Real· 2 shared S. Kim-Schulze· 2 shared A. Charap· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

B. Lee

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 1, 2023

Understanding the heterogeneity of alloreactive natural killer cell function inkidney transplantation

D. F. Ruan, M. Fribourg, Y. Yuki…·A. Horowitz

This study identifies NK cell subpopulations and their functional responses in kidney transplant patients, linking pre-transplant NK cell characteristics to long-term graft function.

DOI 10.1101/2023.09.01.555962

humanflow cytometry

𝕏 PostBluesky

ImmunologybioRxivPreprintMar 4, 2022

NKG2A and HLA-E define a novel alternative immune checkpoint axis in bladder cancer

B. Salome, J. P. Sfakianos, J. Daza…·Mariath

This study identifies NKG2A and HLA-E as an alternative immune checkpoint axis in bladder cancer, showing NKG2A+ CD8 T cells can bypass HLA-ABC loss through TCR-independent cytotoxicity.

DOI 10.1101/2022.03.04.482960

humanflow cytometry

𝕏 PostBluesky